**Core Concept**
Biguanides are a class of oral hypoglycemic agents used in the management of type 2 diabetes mellitus. They work primarily by decreasing hepatic gluconeogenesis and increasing insulin sensitivity.

**Why the Correct Answer is Right**
Biguanides, such as metformin, are contraindicated in patients with renal dysfunction because they are primarily excreted by the kidneys. In patients with impaired renal function, metformin can accumulate to toxic levels, leading to lactic acidosis, a potentially life-threatening condition. Therefore, option B is incorrect because biguanides are indeed contraindicated in renal dysfunction.

**Why Each Wrong Option is Incorrect**
* **Option A:** This is correct because biguanides, such as metformin, do decrease hepatic gluconeogenesis by inhibiting the enzyme glucose-6-phosphatase and decreasing the expression of key gluconeogenic enzymes.
* **Option C:** This is correct because biguanides can be used in combination with sulfonylureas to enhance glycemic control. Sulfonylureas stimulate insulin release from pancreatic beta cells, while biguanides increase insulin sensitivity and decrease hepatic gluconeogenesis.
* **Option D:** This is correct because biguanides do not stimulate insulin release directly. Instead, they increase insulin sensitivity and decrease hepatic gluconeogenesis, leading to improved glycemic control.

**Clinical Pearl / High-Yield Fact**
It's essential to remember that biguanides, such as metformin, can cause gastrointestinal side effects, including diarrhea and abdominal pain. However, these side effects are usually dose-related and can be managed by titrating the dose or switching to a different formulation.

**✓ Correct Answer: B. Not contraindicated in renal dysfunction**